We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-13.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.1B
AUM Growth
-$8.74B
(-19%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
799
New
91
Increased
212
Reduced
361
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$347M |
| 2 |
Wayfair
W
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$140M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$131M |
| 5 |
CVS Health
CVS
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$946M |
| 2 |
SHPG
Shire pic
SHPG
|
+$472M |
| 3 |
Deere & Co
DE
|
+$326M |
| 4 |
COL
Rockwell Collins
COL
|
+$286M |
| 5 |
ANDV
Andeavor
ANDV
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Technology | 13.74% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROV
526
DELISTED
Urovant Sciences Ltd.
UROV
| $9.13M | 0.03% |
1,385,000
+170,000
| +14% | +$1.55M |
|
527
Franklin Resources
BEN
$17.6B
| $9.1M | 0.03% |
306,900
+260,500
| +561% | +$8.01M |
|
528
Howmet Aerospace
HWM
$113B
| $9.07M | 0.03% |
701,552
-4,042
| -0.6% | -$63.2K |
|
529
Idexx Laboratories
IDXX
$44.1B
| $8.95M | 0.02% |
48,094
-138,849
| -74% | -$28.5M |
|
|
SCG
530
DELISTED
Scana
SCG
| $8.88M | 0.02% |
185,782
+46,147
| +33% | +$1.98M |
|
531
PVH
PVH
$4B
| $8.87M | 0.02% |
+95,400
| New | +$10.9M |
|
532
Insmed
INSM
$21.4B
| $8.82M | 0.02% |
672,000
-578,000
| -46% | -$9.22M |
|
533
SL Green Realty
SLG
$3.76B
| $8.81M | 0.02% |
115,078
-5,372
| -4% | -$475K |
|
534
Crinetics Pharmaceuticals
CRNX
$8.84B
| $8.7M | 0.02% |
290,000
+90,000
| +45% | +$2.53M |
|
535
SAP
SAP
$212B
| $8.46M | 0.02% |
+85,000
| New | +$9.04M |
|
|
XENT
536
DELISTED
Intersect ENT, Inc
XENT
| $8.45M | 0.02% |
300,000
+150,000
| +100% | +$4.39M |
|
537
Invesco
IVZ
$13.1B
| $8.43M | 0.02% |
503,669
-25,000
| -5% | -$500K |
|
|
FPRX
538
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.37M | 0.02% |
900,000
+252,000
| +39% | +$3M |
|
539
Pultegroup
PHM
$24.1B
| $8.36M | 0.02% |
321,800
-15,700
| -5% | -$388K |
|
|
AIV
540
Aimco
AIV
$387M
| $8.34M | 0.02% |
1,427,028
-70,564
| -5% | -$420K |
|
|
AY
541
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $8.22M | 0.02% |
+419,624
| New | +$8.32M |
|
542
Xenon Pharmaceuticals
XENE
$6.06B
| $8.2M | 0.02% |
1,300,000
+100,000
| +8% | +$889K |
|
|
REN
543
DELISTED
Resolute Energy Corporaton
REN
| $8.16M | 0.02% |
+281,587
| New | +$8.89M |
|
544
Unum
UNM
$13.6B
| $7.99M | 0.02% |
271,869
-13,300
| -5% | -$465K |
|
|
GRMN
545
Garmin
GRMN
$56.7B
| $7.88M | 0.02% |
124,412
-7,300
| -6% | -$473K |
|
546
Ambarella
AMBA
$3.77B
| $7.87M | 0.02% |
225,000
+175,000
| +350% | +$6.2M |
|
547
Incyte
INCY
$24.2B
| $7.83M | 0.02% |
123,097
+40,280
| +49% | +$2.62M |
|
548
Amphenol
APH
$198B
| $7.8M | 0.02% |
385,344
-853,200
| -69% | -$18.3M |
|
|
ICD
549
DELISTED
Independence Contract Drilling, Inc.
ICD
| $7.73M | 0.02% |
123,935
-1,078
| -0.9% | -$81.1K |
|
|
WP
550
DELISTED
Worldpay, Inc.
WP
| $7.64M | 0.02% |
100,000
-616,000
| -86% | -$53.6M |
|
Similar funds
Adage Capital Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Adage Capital Partners held 799 positions worth $36.1B, down 19% from $44.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Adage Capital Partners withdrew a net $2.16B in Q4 2018, closing 95 positions and reducing 361 holdings. Its most notable exit was Aetna Inc, an estimated $946M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in CVS Health worth $106M.
- Adage Capital Partners's largest Q4 2018 buy was CVS Health: 1,619,774 shares worth $106M.
- Adage Capital Partners added most to GE Aerospace in Q4 2018, an estimated $347M increase.
- Adage Capital Partners's biggest Q4 2018 reduction was Shire pic, cutting an estimated $472M.
- Adage Capital Partners fully exited Aetna Inc in Q4 2018, selling an estimated $946M.
- Adage Capital Partners's ten largest holdings make up 16% of its $36.1B portfolio in Q4 2018.
- Adage Capital Partners opened 91 new positions and closed 95 in Q4 2018.
- Adage Capital Partners's portfolio value fell 19% quarter-over-quarter to $36.1B.
Based on Adage Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.